Cigarette smoking impairs bradykinin-stimulated tissue plasminogen activator release in human coronary circulation

Thrombosis Research

Volumn 120, Issue 6, 2007, Pages 791-796

  Takashima, Hiroyuki ^a   Matsumoto, Tetsuya ^a   Nakae, Ichiro ^a   Yamane, Tetsunobu ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Bradykinin; Cigarette smoking; Coronary blood flow; Tissue plasminogen activator

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; NITRIC ACID DERIVATIVE; PAPAVERINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; PRIORITY JOURNAL;

BRADYKININ; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY THROMBOSIS; FEMALE; FIBRINOGEN; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PAPAVERINE; RISK FACTORS; SMOKING; TISSUE PLASMINOGEN ACTIVATOR; VASODILATOR AGENTS;

EID: 34548667451     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.10.024     Document Type: Article

References (25)

1. Chen L., Chester M., and Kaski J.C. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 108 (1995) 364-369
2. Njolstad I., Arnesen E., and Lund-Larsen P.G. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: a 12-year follow-up of the Finnmark study. Circulation 93 (1996) 450-456
3. Mamun A.A., Peeters A., Barendregt J., Willekens F., Nusselder W., and Bonneux L. Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study. Eur Heart J 25 (2004) 409-415
4. Burke A.P., Farb A., Malcom G.T., Liang Y.-H., Smialek J., and Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336 (1997) 1276-1282
5. Celermajer D.S., Sorensen K.E., Georgakopoulos D., Bull C., Thomas O., Robinson J., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults. Circulation 88 part 1 (1993) 2149-2155
6. Celermajer D.S., Adams M.R., Clarkson P., Robinson J., McCredie R., Donald A., et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334 (1996) 150-154
7. Node K., Kitakaze M., Yoshikawa H., Kosaka H., and Hori M. Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 79 (1997) 1538-1541
8. Kawai Y., Matsumoto Y., Watanabe K., Yamamoto H., Satoh K., Murata M., et al. Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells. Blood 87 (1996) 2314-2321
9. Lijnen H.R., and Collen D. Endothelium in hemostasis and thrombosis (review). Prog Cardiovasc Dis 39 (1997) 343-350
10. Pretorius M., Rosenbaum D.A., Lefebvre J., Vaughan D.E., and Brown N.J. Smoking impairs bradykinin-stimulated t-PA release. Hypertension 39 (2002) 767-771
11. Linz W., Wiemer G., and Scholkens B.A. Beneficial effect of bradykinin on myocardial energy metabolism and infarct size. Am J Cardiol 80 (1997) 118A-123A
12. Nakashima M., Mombouli J.-V., Taylor A.A., and Vanhoutte P.M. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 92 (1993) 2867-2871
13. Toda N., and Okamura T. Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries. Am J Physiol 257 (1989) H988-H995
14. Brown N.J., Gainer J.V., Stein M., and Vaughan D.E. Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 33 (1999) 1431-1435
15. Minai K., Matsumoto T., Horie H., Ohira N., Takashima H., Yokihama H., et al. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 37 (2001) 1565-1570
16. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006) 180-189
17. Newby D.E., McLeod A.L., Uren N.G., Flint L., Ludlam C.A., Webb D.J., et al. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking. Direct link between endothelial dysfunction and atherothrombosis. Circulation 103 (2001) 1936-1941
18. Newby D.E., Wright R.A., Labinjoh C., Ludlam C.A., Fox K.A.A., Boon N.A., et al. Endothelial dysfunction, impaired endogenous fibrolysis, and cigarette smoking. A mechanism for arterial thrombosis and myocardial infarction. Circulation 99 (1999) 1411-1415
19. Brown N.J., Gainer J.V., Murphey L.J., and Vaughan D.E. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation 102 (2000) 2190-2196
20. Newby D.E., Wright R.A., Dawson P., Ludlam C.A., Boon N.A., Fox K.A., et al. The l-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res 38 (1998) 485-492
21. Labinjoh C., Newby D.E., Pellegrini P., Johnston N.R., Boon N.A., and Webb D.J. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition. J Am Coll Cardiol 38 (2001) 1402-1408
22. Matsumoto T., Minai K., Horie H., Ohira N., Takashima H., Tarutani Y., et al. Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients. J Am Coll Cardiol 41 (2003) 1373-1379
23. Yugar-Toledo J.C., Tanus-Santos J.E., Sabha M., Sousa M.G., Cittadino M., Tacito L.H.B., et al. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest 125 (2004) 823-830
24. McVeigh G.E., Lemay L., Morgan D., and Cohn J.N. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 78 (1996) 668-672
25. Pellegrini M.P., Newby D.E., Maxwell S., and Webb D.J. Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man. Cardiovasc Res 52 (2001) 321-327